BioCentury
ARTICLE | Company News

Affitech, Cancer Research U.K. deal

May 2, 2011 7:00 AM UTC

Affitech received exclusive, worldwide rights from Cancer Research's Cancer Research Technology Ltd. commercial arm to a patent application and IP to develop antibodies against tumor protein CC chem...